Related Articles
Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer
Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer
PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells
Role of gambogic acid and NaI131 in A549/DDP cells
Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: A potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population